Where do Bristol-Myers Squibb's ratios come from?

Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	281.3%0.0pp	281.3%0.0pp	281.3%-5.4pp	286.7%-5.1pp	291.8%-5.2pp
Net margin	52.5%+3.8pp	48.7%+33.3pp	15.4%+27.7pp	-12.3%+24.5pp	-36.8%+24.7pp
EBITDA margin	108.5%-2.2pp	110.8%+25.5pp	85.2%+19.6pp	65.6%+19.3pp	46.3%+20.6pp
Free cash flow margin	113.6%-2.9pp	116.5%-2.2pp	118.8%+2.8pp	116%+2.7pp	113.3%0.0pp
Returns
Return on equity	141.7%+7.3pp	134.4%+79.9pp	54.5%+64.9pp	-10.4%+55.6pp	-66%+57.0pp
Return on assets	27.4%+2.5pp	24.8%+17.3pp	7.5%+14.1pp	-6.6%+12.2pp	-18.8%+11.9pp
Return on invested capital	44.5%+4.2pp	40.2%+27.2pp	13%+22.0pp	-9%+18.5pp	-27.5%+18.1pp
Efficiency
Asset turnover	2.1×0.0×	2×0.0×	2×0.0×	2×0.0×	2×0.0×
Inventory turnover	20.3×+0.3×	20×0.0×	20×-0.9×	20.9×-1.2×	22.1×-1.3×
Liquidity
Current ratio	5.1×+0.1×	5×0.0×	5×0.0×	5×+0.1×	4.9×+0.2×
Quick ratio	4.7×+0.1×	4.6×0.0×	4.6×+0.1×	4.5×+0.1×	4.4×+0.2×
Cash ratio	2×0.0×	1.9×0.0×	1.9×+0.2×	1.7×+0.2×	1.5×+0.1×
Leverage
Debt-to-equity	10.3×-0.6×	10.9×-0.6×	11.5×-0.3×	11.7×-0.3×	12×-0.5×
Debt-to-assets	2.1×0.0×	2.1×0.0×	2.1×0.0×	2.1×0.0×	2.2×0.0×
Net debt / EBITDA	10.9×-0.1×	11×-36.3×	47.3×-10.1×	57.4×-10.0×	67.4×-8.8×
Valuation
Market capitalization	$421.15B-0.1%	$421.42B-1.2%	$426.32B-3.0%	$439.42B+2.7%	$427.9B+3.5%
Enterprise value	$563.41B-0.7%	$567.6B-1.5%	$576.43B-3.6%	$598.09B+0.3%	$596.06B+1.2%
Price / earnings	67.2×-6.2×	73.4×—	——	——	——
Price / sales	8.8×-0.1×	8.8×-0.1×	8.9×-0.3×	9.2×+0.2×	9×+0.2×
Price / book	22.6×-1.0×	23.5×-1.1×	24.6×-1.2×	25.8×+0.5×	25.2×+0.5×
EV / EBITDA	43.1×+0.4×	42.7×-138×	180.4×-34.7×	215.1×-25.9×	241×-27.2×
EV / sales	11.7×-0.1×	11.9×-0.2×	12×-0.5×	12.5×0.0×	12.5×0.0×
Free cash flow yield	53.2%-0.9pp	54.1%-0.5pp	54.6%+3.5pp	51.1%-0.1pp	51.2%-0.9pp
Earnings yield	24%+1.6pp	22.4%+14.3pp	8.1%+13.4pp	-5.3%+13.0pp	-18.2%+9.9pp
Dividend yield	19.3%+0.1pp	19.2%+0.4pp	18.8%+0.9pp	18%-0.5pp	18.5%-0.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bristol-Myers Squibb.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Bristol-Myers Squibb's ratios come from?: Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.